Cancer is one of the leading causes of death, thereby, contributing to their quick diagnosis or treatment is of greatest importance. Nowadays, tumours are mainly diagnosed and graded histologically using biopsies. Since the images need to be sharp to distinguish biological structures, samples are thinly sliced (3-5 μm) to avoid scattering and contrast is obtained using highly absorbance dyes (e.g., Haematoxylin and Eosin (H&E)). RGB (Red-Green-Blue) cameras have been widely employed to acquire those images, while new approaches, such as Hyperspectral (HS) Imaging (HSI), have been arising to obtain a greater amount of spectral information from the samples. However, in order to have diffuse light for the HS cameras to capture it, the thickness of the sample should be bigger than the ones employed in conventional microscopy. This work aims to characterize the influence of tissue thickness of histology breast samples sectioned at 2 and 3 μm on their spectral signatures. Based on the H&E transmittance spectra peaks, HS images were segmented into three structures: stroma (eosin-stained), nuclei (haematoxylin-stained), and background (non-stained). Results show that, spatially, in 3 μm samples there are more cells imaged than in 2 μm samples. Moreover, spectrally, 3 μm samples proportionate higher spectral contrast than 2 μm samples due the greater interaction of light with tissue, denoting them as more suitable for microscopic HSI.
The early detection of precancerous cervical lesions is essential to improve patient treatment and prognosis. Hyperspectral (HS) imaging (HSI) has demonstrated a high potential to become a new non-invasive and label-free imaging technique in the medical field for performing quick diagnosis of different diseases. This study presents the research and development process to integrate and characterize a KURIOS-XE2 filter (Thorlabs, Inc., NJ, USA), based in a liquid crystal tunable filter (LCTF) technology, into an existing colposcope (C5, OPTOMIC, Spain). The main goal was to capture spectral information in the near infrared range (650 to 1100nm) by using a monochrome camera and acquiring 90 spectral wavelengths with a spectral resolution of 5nm. Two different integration strategies were studied: i) filtering the emitted light by the sensor and ii) filtering the received light by the sensor, evaluating their respective benefits and limitations. Furthermore, a custom software was developed for HS image acquisition, integrating a variable acquisition time per wavelength, which allows improving the signal-to-noise ratio at wavelengths where the system presents lower quantum efficiency. The proposed system simplifies the adaptation of existing optical systems to HSI technology, improving the signal-to-noise ratio in the studied spectral range respect to other approaches. The results were compared against a previous custom implementation based on a Snapscan camera (IMEC, Belgium), covering the visual and near infrared and highlighting the advantages and limitations of both technologies for the development of a HS colposcope system targeting early detection of precancerous cervical lesions during routine clinical practice.
The incidence of skin cancer has increased in the last decades, being one of the most common cancers, but can have a five-year survival rate of over 99% if treated early. This work describes a novel hyperspectral dermoscope for early skin cancer detection, able to capture spatial and spectral information in the Visible (VIS) and Near Infrared (NIR) ranges by using Liquid Crystal Tunable Filters (LCTFs). KURIOS-VB1 and KURIOS-XE2 filters were used for VIS and NIR ranges, respectively, providing 136 wavelengths with 5 nm of spectral resolution. A dichroic mirror combines output light paths, illuminating the skin's surface via a fiber optic ring light. Reflected light is captured by a 1.3-megapixel monochrome camera. Additionally, a custom hand-held 3D printed part integrates optics and control circuitry. The proposed characterization method used to optimize the camera exposure time for each wavelength has proven effective in obtaining a flat white reference and gathering information in the range of 450 to 1050 nm and, especially, at critical wavelengths such as the test wavelengths evaluated closer to the limit bands of the LCFTs (450 and 600 nm for VIS, and 750 and 900 nm for NIR).
KEYWORDS: RGB color model, Tumors, Principal component analysis, Tissues, Cancer detection, Object detection, Visualization, Hyperspectral imaging, Data modeling
The current advances in Whole-Slide Imaging (WSI) scanners allow for more and better visualization of histological slides. However, the analysis of histological samples by visual inspection is subjective and could be challenging. State-of-the-art object detection algorithms can be trained for cell spotting in a WSI. In this work, a new framework for the detection of tumor cells in high-resolution and high-detail using both RGB and Hyperspectral (HS) imaging is proposed. The framework introduces techniques to be trained on partially labeled data, since labeling at the cellular level is a time and energy-consuming task. Furthermore, the framework has been developed for working with RGB and HS information reduced to 3 bands. Current results are promising, showcasing in RGB similar performance as reference works (F1-score = 66.2%) and high possibilities for the integration of reduced HS information into current state-of-art deep learning models, with current results improving the mean precision a 6.3% from synthetic RGB images.
Glioblastoma surgical resection is a problematic mission for neurosurgeons. Tumor complete resection improves patients healing chances and prognosis, whilst excessive resection could lead to neurological deficits. Nevertheless, surgeons' sight hardly traces the tumor's extent and boundaries. Indeed, most surgical processes result in subtotal resections. Histopathological testing might enable complete tumor elimination, though it is not feasible due to the time required for tissue investigation. Several studies reported tumor cells having unique molecular signatures and properties. Hyperspectral Imaging (HSI) is an emerging, non-contact, non-ionizing, label-free and minimally invasive optical imaging technique able to extract information concerning the observed tissue at the molecular level. Here, we exploited extensive data augmentation, transfer learning, the U-Net++ and the DeepLab-V3+ architectures to perform the automatic end-to-end segmentation of intraoperative glioblastoma hyperspectral images meeting competitive processing times and segmentation results concerning the gold-standard procedure. Based on ground truths provided by the HELICoiD framework, we dramatically improved HSIs processing times, enabling the end-to-end segmentation of glioblastomas targeting the real-time processing to be employed during open craniotomy in surgery, thus improving the gold-standard ML pipeline. We measured competitive inference times concerning the standard CUDA environment offered by MatLab 2020a. The HELICoiD fastest parallel version took 1.68 s to elaborate the most prominent image of the database, whilst our methodology performs segmentation inference in 0.29 ± 0.17 s, hence being real-time compliant concerning the 21 seconds constraint imposed on processing. Furthermore, we evaluated our segmentation results qualitatively and quantitatively regarding the ground truth produced by HELICoiD.
Hyperspectral (HS) imaging (HSI) is a novel technique that allows a better understanding of materials, being an improvement respect to other imaging modalities in multiple applications. Specifically, HSI technology applied to breast cancer histology, could significantly reduce the time of tumor diagnosis at the histopathology department. First, histological samples from twelve different breast cancer patients have been prepared and examined. Second, they were digitally scanned, using RGB (Red-Green-Blue) whole-slide imaging, and further annotated at cell level. Then, the annotated regions were captured with an HS microscopic acquisition system at 20× magnification, covering the 400-1000 nm spectral range. The HS data was registered (through synthetic RGB images) to the whole-slide images, allowing the transfer of accurate annotations made by pathologists to the HS image and extract each annotated cell from such image. Then, both spectral and spatial-spectral classifications were carried out to automatically detect tumor cells from the rest of the coexisting cells in the breast tissue (fibroblasts and lymphocytes). In this work, different supervised classifiers have been employed, namely kNN (k-Nearest-Neighbors), Random Forest, DNN (Deep Neural Network), Support Vector Machines (SVM) and CNN (Convolutional Neural Network). Test results for tumor cells vs. fibroblast classification show that the kNN performed with the best sensitivity/specificity (64/52%) trade-off and the CNN achieved the best sensitivity and AUC results (96% and 0.91, respectively). Moreover, at the tumor cells vs. lymphocyte classification, kNN also provided the best sensitivity-specificity ratio (58.47/58.86%) and an F1-score of 74.12%. The SVM algorithm also provided a high F-score result (70.38%). In conclusion, several machine learning algorithms provide promising results for cell classification in breast cancer tissue and so, future work must include these discoveries for faster cancer diagnosis.
Accurate identification of tumor boundaries during brain cancer surgery determines the quality of life of the patient. Different intraoperative guidance tools are currently employed during the resection tumor but having several limitations. Hyperspectral imaging (HSI) is arising as a label-free and non-ionizing technique that could assist neurosurgeons during surgical procedures. In this paper, an analysis between in-vivo and ex-vivo human brain tumor samples using HSI has been performed to evaluate the correlation between both types of samples. Spectral ratios of the oxygenated and deoxygenated hemoglobin were employed to distinguish between normal tissue, tumor tissue and blood vessels. A database composed by seven in-vivo and fourteen ex-vivo hyperspectral images obtained from seven different patients diagnosed with glioblastoma Grade IV, metastatic secondary breast cancer, meningioma Grade I and II, and astrocytoma (glioma) Grade II. 44,964 pixels labeled pixels were employed in this work. The proposed method achieved discrimination between different tissue types using the proposed spectral ratio. Comparison between in-vivo and ex-vivo samples indicated that ex-vivo samples generate higher hemoglobin ratios. Moreover, vascular enhanced maps were generated using the spectral ratio, targeting real-time intraoperative surgical assistance.
Surgery is a crucial treatment for malignant brain tumors where gross total resection improves the prognosis. Tissue samples taken during surgery are either subject to a preliminary intraoperative histological analysis, or sent for a full pathological evaluation which can take days or weeks. Whereas a lengthy complete pathological analysis includes an array of techniques to be executed, a preliminary tissue analysis on frozen tissue is performed as quickly as possible (30-45 minutes on average) to provide fast feedback to the surgeon during the surgery. The surgeon uses the information to confirm that the resected tissue is indeed tumor and may, at least in theory, initiate repeated biopsies to help achieve gross total resection. However, due to the total turn-around time of the tissue inspection for repeated analyses, this approach may not be feasible during a single surgery. In this context, intraoperative image-guided techniques can improve the clinical workflow for tumor resection and improve outcome by aiding in the identification and removal of the malignant lesion. Hyperspectral imaging (HSI) is an optical imaging technique with the potential to extract combined spectral-spatial information. By exploiting HSI for human brain-tissue classification in 13 in-vivo hyperspectral images from 9 patients, a brain-tissue classifier is developed. The framework consists of a hybrid 3D-2D CNN-based approach and a band-selection step to enhance the capability of extracting both spectral and spatial information from the hyperspectral images. An overall accuracy of 77% was found when tumor, normal and hyper-vascularized tissue are classified, which clearly outperforms the state-of-the-art approaches (SVM, 2D-CNN). These results may open an attractive future perspective for intraoperative brain-tumor classification using HSI.
Hyperspectral imaging (HSI), which acquires up to hundreds of bands, has been proposed as a promising imaging modality for digitized histology beyond RGB imaging to provide more quantitative information to assist pathologists with disease detection in samples. While digitized RGB histology is quite standardized and easy to acquire, histological HSI often requires custom-made equipment and longer imaging times compared to RGB. In this work, we present a dataset of corresponding RGB digitized histology and histological HSI of breast cancer, and we develop a conditional generative adversarial network (GAN) to artificially synthesize HSI from standard RGB images of normal and cancer cells. The results of the GAN synthesized HSI are promising, showing structural similarity (SSIM) of approximately 80% and mean absolute error (MAE) of 6 to 11%. Further work is needed to establish the ability of generating HSI from RGB images on larger datasets.
In recent years, hyperspectral imaging (HSI) has been shown as a promising imaging modality to assist pathologists in the diagnosis of histological samples. In this work, we present the use of HSI for discriminating between normal and tumor breast cancer cells. Our customized HSI system includes a hyperspectral (HS) push-broom camera, which is attached to a standard microscope, and home-made software system for the control of image acquisition. Our HS microscopic system works in the visible and near-infrared (VNIR) spectral range (400 - 1000 nm). Using this system, 112 HS images were captured from histologic samples of human patients using 20× magnification. Cell-level annotations were made by an expert pathologist in digitized slides and were then registered with the HS images. A deep learning neural network was developed for the HS image classification, which consists of nine 2D convolutional layers. Different experiments were designed to split the data into training, validation and testing sets. In all experiments, the training and the testing set correspond to independent patients. The results show an area under the curve (AUCs) of more than 0.89 for all the experiments. The combination of HSI and deep learning techniques can provide a useful tool to aid pathologists in the automatic detection of cancer cells on digitized pathologic images.
Head and neck squamous cell carcinoma (SCC) is primarily managed by surgical cancer resection. Recurrence rates after surgery can be as high as 55%, if residual cancer is present. Hyperspectral imaging (HSI) is evaluated for detection of SCC in ex-vivo surgical specimens. Several machine learning methods are investigated, including convolutional neural networks (CNNs) and a spectral–spatial classification framework based on support vector machines. Quantitative results demonstrate that additional data preprocessing and unsupervised segmentation can improve CNN results to achieve optimal performance. The methods are trained in two paradigms, with and without specular glare. Classifying regions that include specular glare degrade the overall results, but the combination of the CNN probability maps and unsupervised segmentation using a majority voting method produces an area under the curve value of 0.81 [0.80, 0.83]. As the wavelengths of light used in HSI can penetrate different depths into biological tissue, cancer margins may change with depth and create uncertainty in the ground truth. Through serial histological sectioning, the variance in the cancer margin with depth is investigated and paired with qualitative classification heat maps using the methods proposed for the testing group of SCC patients. The results determined that the validity of the top section alone as the ground truth may be limited to 1 to 2 mm. The study of specular glare and margin variation provided better understanding of the potential of HSI for the use in the operating room.
Head and neck squamous cell carcinoma (SCCa) is primarily managed by surgical resection. Recurrence rates after surgery can be as high as 55% if residual cancer is present. In this study, hyperspectral imaging (HSI) is evaluated for detection of SCCa in ex-vivo surgical specimens. Several methods are investigated, including convolutional neural networks (CNNs) and a spectral-spatial variant of support vector machines. Quantitative results demonstrate that additional processing and unsupervised filtering can improve CNN results to achieve optimal performance. Classifying regions that include specular glare, the average AUC is increased from 0.73 [0.71, 0.75 (95% confidence interval)] to 0.81 [0.80, 0.83] through an unsupervised filtering and majority voting method described. The wavelengths of light used in HSI can penetrate different depths into biological tissue, while the cancer margin may change with depth and create uncertainty in the ground-truth. Through serial histological sectioning, the variance in cancer-margin with depth is also investigated and paired with qualitative classification heat maps using the methods proposed for the testing group SCC patients.
Brain cancer surgery has the goal of performing an accurate resection of the tumor and preserving as much as possible the quality of life of the patient. There is a clinical need to develop non-invasive techniques that can provide reliable assistance for tumor resection in real-time during surgical procedures. Hyperspectral imaging (HSI) arises as a new, noninvasive and non-ionizing technique that can assist neurosurgeons during this difficult task. In this paper, we explore the use of deep learning (DL) techniques for processing hyperspectral (HS) images of in-vivo human brain tissue. We developed a surgical aid visualization system capable of offering guidance to the operating surgeon to achieve a successful and accurate tumor resection. The employed HS database is composed of 26 in-vivo hypercubes from 16 different human patients, among which 258,810 labelled pixels were used for evaluation. The proposed DL methods achieve an overall accuracy of 95% and 85% for binary and multiclass classifications, respectively. The proposed visualization system is able to generate a classification map that is formed by the combination of the DL map and an unsupervised clustering via a majority voting algorithm. This map can be adjusted by the operating surgeon to find the suitable configuration for the current situation during the surgical procedure.
Hyperspectral Imaging (HI) assembles high resolution spectral information from hundreds of narrow bands across the electromagnetic spectrum, thus generating 3D data cubes in which each pixel gathers the spectral information of the reflectance of every spatial pixel. As a result, each image is composed of large volumes of data, which turns its processing into a challenge, as performance requirements have been continuously tightened. For instance, new HI applications demand real-time responses. Hence, parallel processing becomes a necessity to achieve this requirement, so the intrinsic parallelism of the algorithms must be exploited. In this paper, a spatial-spectral classification approach has been implemented using a dataflow language known as RVCCAL. This language represents a system as a set of functional units, and its main advantage is that it simplifies the parallelization process by mapping the different blocks over different processing units. The spatial-spectral classification approach aims at refining the classification results previously obtained by using a K-Nearest Neighbors (KNN) filtering process, in which both the pixel spectral value and the spatial coordinates are considered. To do so, KNN needs two inputs: a one-band representation of the hyperspectral image and the classification results provided by a pixel-wise classifier. Thus, spatial-spectral classification algorithm is divided into three different stages: a Principal Component Analysis (PCA) algorithm for computing the one-band representation of the image, a Support Vector Machine (SVM) classifier, and the KNN-based filtering algorithm. The parallelization of these algorithms shows promising results in terms of computational time, as the mapping of them over different cores presents a speedup of 2.69x when using 3 cores. Consequently, experimental results demonstrate that real-time processing of hyperspectral images is achievable.
Hyperspectral Imaging (HI) collects high resolution spectral information consisting of hundreds of bands across the electromagnetic spectrum –from the ultraviolet to the infrared range–. Thanks to this huge amount of information, an identification of the different elements that compound the hyperspectral image is feasible. Initially, HI was developed for remote sensing applications and, nowadays, its use has been spread to research fields such as security and medicine. In all of them, new applications that demand the specific requirement of real-time processing have appear. In order to fulfill this requirement, the intrinsic parallelism of the algorithms needs to be explicitly exploited.
In this paper, a Support Vector Machine (SVM) classifier with a linear kernel has been implemented using a dataflow language called RVC-CAL. Specifically, RVC-CAL allows the scheduling of functional actors onto the target platform cores. Once the parallelism of the classifier has been extracted, a comparison of the SVM classifier implementation using LibSVM –a specific library for SVM applications– and RVC-CAL has been performed.
The speedup results obtained for the image classifier depends on the number of blocks in which the image is divided; concretely, when 3 image blocks are processed in parallel, an average speed up above 2.50, with regard to the RVC-CAL sequential version, is achieved.
Hyperspectral images allow obtaining large amounts of information about the surface of the scene that is captured by the sensor. Using this information and a set of complex classification algorithms is possible to determine which material or substance is located in each pixel. The HELICoiD (HypErspectraL Imaging Cancer Detection) project is a European FET project that has the goal to develop a demonstrator capable to discriminate, with high precision, between normal and tumour tissues, operating in real-time, during neurosurgical operations. This demonstrator could help the neurosurgeons in the process of brain tumour resection, avoiding the excessive extraction of normal tissue and unintentionally leaving small remnants of tumour. Such precise delimitation of the tumour boundaries will improve the results of the surgery. The HELICoiD demonstrator is composed of two hyperspectral cameras obtained from Headwall. The first one in the spectral range from 400 to 1000 nm (visible and near infrared) and the second one in the spectral range from 900 to 1700 nm (near infrared). The demonstrator also includes an illumination system that covers the spectral range from 400 nm to 2200 nm. A data processing unit is in charge of managing all the parts of the demonstrator, and a high performance platform aims to accelerate the hyperspectral image classification process. Each one of these elements is installed in a customized structure specially designed for surgical environments. Preliminary results of the classification algorithms offer high accuracy (over 95%) in the discrimination between normal and tumour tissues.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.